Kezar Life Sciences, Inc. (KZR) Operating Lease, Payments USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kezar Life Sciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Kezar Life Sciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $711 K, a 17.5% increase year-over-year.
  • Kezar Life Sciences, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $2.67 M, a 97.3% increase year-over-year.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2023 was $2.57 M, a 149% increase from 2022.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2022 was $1.03 M, a 0.96% decline from 2021.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2021 was $1.04 M, a 15.8% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.67 M $711 K +$106 K +17.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.57 M $681 K +$535 K +366% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $2.03 M $649 K +$344 K +113% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.69 M $631 K +$333 K +112% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.35 M $605 K +$322 K +114% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.03 M $146 K -$126 K -46.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.16 M $305 K +$39 K +14.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.12 M $298 K +$39 K +15.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.08 M $283 K +$38 K +15.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.04 M $272 K +$37 K +15.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $1.01 M $266 K +$36 K +15.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $969 K $259 K +$35 K +15.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $934 K $245 K +$34 K +16.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $900 K $235 K +$33 K +16.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 $867 K $230 K +$32 K +16.2% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $835 K $224 K +$31 K +16.1% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $804 K $211 K +$30 K +16.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $774 K $202 K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $198 K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $193 K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $181 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.